DSpace

King Saud University Repository >
King Saud University >
RESEARCH CENTERS >
Faculty of Pharmacy Research Center >
Faculty of Pharmacy Research Center >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/2942

Title: Bioequivalence evaluation of lomefloxacin 400 mg tablets (lomax versus maxaquin) in healthy human volunteers
Authors: Al-Rashooda, Khalid A.
Al-Khamis, Khalil I.
El-Sayed, Yoursy M.
Al-Bella, Sulaiman
Al-Yamani, Mohd A.
Alam, S. Mahmood
Dham, Ruwayda
Keywords: Bioequivalence evaluation
Lomefloxacin
Pharmacokinetic parameters
Health
Human Volunteers
تاريخ النشر: 1999
Publisher: John Wiley & Sons
Citation: Biopharmaceutic & Drug Disposition: 20; 407–410
Abstract: This study represents the results of a randomized, single dose, two-treatment, two-period crossover study in 18 healthy male volunteers to assess the bioequivalence of two tablets of 400 mg lomefloxacin. The two formulations were: Lomax (Julphar, United Arab Emirates) as the test formulation and Maxaquin (Searle, S.A., UK) as the reference formulation. The study was conducted at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, jointly with King Khalid University Hospital, Riyadh, Saudi Arabia. After overnight fasting the two products were administered as a single dose on two treatment days separated by a 1 week washout period. Serial blood samples were collected thereafter, for a period of 48 h. Plasma harvested from blood was analysed for lomefloxacin by a sensitive, reproducible and accurate HPLC method. Various pharmacokinetic parameters including AUC0–t, AUC0– , Cmax, Tmax, T1:2, Kelm and Cmax:AUC0– were determined from plasma concentrations for both formulations and found to be in good agreement with reported values. Statistical modules applied to AUC0–t, AUC0– and Cmax revealed no significant difference in the two tested products. Based on these statistical inferences it was concluded that Lomax is bioequivalent to Maxaquin.
Description: College of Pharmacy, King Saud University
URI: http://hdl.handle.net/123456789/2942
ISSN: 1099-081X
يظهر في المجموعات:Faculty of Pharmacy Research Center

:الملفات في هذا العنصر

ملف وصف حجمالنوع
Bioequivalence evaluation of lomefloxacin 400 mg tablets (lomax versus maxaquin) in healthy human volunteers.pdf116.28 kBAdobe PDFعرض\u0641تح

جميع جميع الابحاث محمية بموجب حقوق الطباعة، جميع الحقوق محفوظة.

 

البرمجيات DSpace حقوق المؤلف © 2002-2009 معهد ماساتشوستس للتكنولوجيا و Hewlet Packard - التغذية الراجعة